Skip to content

Clinical trials

Phase 3 Burkitt Lymphoma trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Burkitt Lymphoma Phase: Phase 3 Country / region: Australia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20032
20071
20111
20121
20141
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting3
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
National Cancer Institute (NCI)3
Baxalta now part of Shire1
NCIC Clinical Trials Group1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Burkitt Lymphoma11
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Lymphoma4
Leukemia3
Lymphoma, Large B-Cell, Diffuse3
Graft vs Host Disease2
Hodgkin Disease2
Leukemia, Biphenotypic, Acute2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Accelerated Phase2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.